Business Wire

Novaliq Names Renown International Experts to Inaugural Scientific Advisory Board

8.9.2016 12:00 | Business Wire

Del

Novaliq GmbH, a pharmaceutical company with a disruptive drug delivery platform to transform poorly soluble drugs into effective therapeutics for ophthalmology, announced today the appointment of several renown experts to its newly formed scientific advisory board (SAB). The newly appointed SAB will strategically advise and support Novaliq as it continues to develop and bring to market innovative therapies for a broad range of ophthalmic indications, including dry eye and glaucoma.

The initial members of the Novaliq SAB include:

  • Claus Cursiefen, M.D., Ph.D., FEBO, chairman and professor, Department of Ophthalmology, University of Cologne, Germany. Prof. Cursiefen’s expertise lies in corneal lymphangiogenesis and cellular immunity in inflammatory eye diseases; corneal transplantation and ocular surface reconstruction; and, dry eye disease. A board member of DFG Neuroscience (“Fachkollegium”) and of the Cornea Section of the German Ophthalmological Society (DOG), Prof. Cursiefen is an internationally recognized speaker and has authored or co-authored more than 300 scientific publications. Prof. Cursiefen is a member of prestigious Leopoldina and Speaker of the only DFG Research Unit in Ophthalmology (www.for2240.de).
  • Norbert Pfeiffer, M.D., Ph.D., chairman and director, Department of Ophthalmology, The University Hospital Mainz, Germany. Prof. Pfeiffer’s research has focused on elucidating important aspects of the diagnosis and treatment of glaucomatous disease combining both morphological and functional aspects, and introducing basic science methods into the clinical diagnosis and treatment of glaucoma. A member of several national and international societies, including the American Academy of Ophthalmology (AAO), the Association for Research in Vision and Ophthalmology (ARVO), and the prestigious Leopoldina, Prof. Pfeiffer has authored or co-authored more than 400 scientific presentations and was awarded several scientific prizes including the Galenus von Pergamon prize.
  • Michael E. Stern, Ph.D., chief scientific officer, ImmunEyez, LLC, Orange County, California. Formerly the principal scientist as well as the vice president of Inflammation Research Program at Allergan where he worked for more than 26 years, Dr. Stern’s focus has been on identifying novel mechanisms and drug targets for immune-based inflammatory diseases that affect the ocular surface. His research has been instrumental to understanding the immunopathogenesis of ocular inflammatory disease and has led to the identification of target specific therapeutics, including RESTASIS®, the first FDA approved therapy for the treatment of dry eye disease. Dr. Stern has authored or co-authored more than 300 scientific publications and abstracts, is on the editorial board of The Ocular Surface, Journal of Ocular Pharmacology and Therapeutics, and Investigative Ophthalmology and Visual Science. He has received many honors, including the Diaz Caneja Award and the International Ocular Surface Society Award.
  • Kazuo Tsubota, M.D., chairman and professor of Ophthalmology, Keio University School of Medicine, Tokyo, Japan and co-director of Health Science Laboratory, Keio University-Shonan Fujisawa Campus, Kanagawa, Japan. An expert in tear film and ocular surface disease, Prof. Tsubota is a member of several national and international societies, including AAO, ARVO, and the American Academy of Cataract & Refractive Surgery (ASCRS), TFOS, and is a founding and board member of Sjogren’s Syndrome Association and Dry Eye Research Group, both in Japan. Prof. Tsubota serves on several editorial boards, has received awards from several ophthalmic societies, and has authored or co-authored more than 700 scientific publications.

"We are pleased and honored to have four distinguished experts in cornea, dry eye and glaucoma joining Novaliq’s team of advisors,” said Bernhard Günther, managing director and CEO of Novaliq GmbH. “I am confident that their experience and background will prove to be invaluable as we move our dry eye and glaucoma drug candidates through clinical development and trials.”

About Novaliq – Novaliq GmbH, founded in 2007, is a Heidelberg based specialty pharmaceutical company focused on ophthalmology. Its mission is to transform poorly soluble drugs into effective ocular therapeutics for both the front and the back of the eye. Novaliq’s proprietary EyeSol® technology enhances the topical bio availability, stability and safety of traditionally insoluble or unstable drugs improving the delivery, efficacy and convenience of treatments for ocular surface diseases including dry eye through preservative free and multi dose formulations. Novaliq’s most advanced product is NovaTears® with CE-marking based on Novaliq’s proprietary EyeSol technology. NovaTears is marketed under the brand name EvoTears® in Europe. More on www.novaliq.com.

Contact information

Europe
Novaliq GmbH
Bernhard Günther, + 49 6221 502 5911
Managing Director, CEO
info@novaliq.de
or
Novaliq GmbH
Oliver Schlüter, PhD, + 49 6221 502 59155
Managing Director, CFO
info@novaliq.de
or
USA
Scotia Vision Consultants
Michael O’Rourke, + 1-813-323-1438
scotiavc@gmail.com

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

Schlumberger Announces Third-Quarter 2017 Results Conference Call16.8.2017 21:23Pressemelding

Schlumberger Limited (NYSE:SLB) will hold a conference call on October 20, 2017 to discuss the results for the third quarter ending September 30, 2017. The conference call is scheduled to begin at 8:30 am US Eastern time and a press release regarding the results will be issued at 7:00 am US Eastern time. To access the conference call, listeners should contact the Conference Call Operator at +1 (800) 288-8967 within North America or +1 (612) 333-4911 outside of North America approximately 10 minutes prior to the start of the call, and ask for the “Schlumberger Earnings Conference Call.” A webcast of the conference call will be broadcast simultaneously at www.slb.com/irwebcast on a listen-only basis. Listeners should log in 15 minutes prior to the start of the call to test their browsers and register for the webcast. Following the end of the conference call,

Rimini Street Named to Inc. 5000 List for Seventh Consecutive Year16.8.2017 18:20Pressemelding

Rimini Street, Inc., a global provider of enterprise software products and services, and the leading independent support provider for Oracle and SAP products, today announced that it was named to Inc. magazine’s 36th annual Inc. 5000 list for the seventh consecutive year. The Inc. 5000 list is an exclusive ranking of the nation’s fastest-growing private companies and represents the most comprehensive look at America’s entrepreneurs. This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20170816005908/en/ Rimini Street has earned a place on the annual Inc. 5000 list since 2011, joining an elite group – approximately 2% – of Inc. 5000 honorees to ever achieve this milestone. (Photo: Business Wire) Rimini Street has earned a place on the annual Inc. 5000 list since 2011, joining an elite group – approximatel

Keio Plaza Hotel Tokyo Starts "Ikebana" Flower Arrangement Workshops16.8.2017 14:00Pressemelding

Keio Plaza Hotel Tokyo, one of Japan’s most prestigious international hotels located in Shinjuku, Tokyo, starts special 45 minute classes to teach overseas guests about “Ikebana” flower arrangement which will be held on every other Thursday beginning from August in a private room for JPY3,000 per participant. Instruction and commentary will be provided by the renowned flower arrangement artist Hiroki Maeno. This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20170816005431/en/ From August, 2017, Keio Plaza Hotel Tokyo starts special 45 minute classes to teach overseas guests about "Ikebana" flower arrangement workshops. (Photo: Business Wire) Flower arrangement artist Hiroki Maeno has created special and unique flower arrangements for display in the main lobby of our hotel with each cha

Maxion Wheels to Feature Market Leading Commercial Vehicle Steel Wheels at COMTRANS 201716.8.2017 13:00Pressemelding

Maxion Wheels, the world’s largest wheel manufacturer, announced today its participation in the biennial COMTRANS / 17 International Commercial Vehicle Show held in Moscow, Russia from September 4 – 9, 2017, in Hall 15/ Stand 15-432. Customers and visitors to the Maxion Wheels exhibit will have the opportunity to learn more about the state-of-the-art commercial vehicle steel wheels that have supported the success of global original equipment manufacturers for almost 100 years. One of the key products on display will be the new 8.5” x 24” wheel for tubeless tire applications in Russia, the Middle East and Africa. The wheel boasts 15 percent less weight than the prior generation wheel, enhancing tire life and improving fuel efficiency. ABOUT MAXION WHEELS Maxion Wheels, a division of IOCHPE-MAXION S.A., is a leading wheel manufacturer for passenger cars,

Out-of-this-World Science Project to be Featured as Keynote at SC17’s High Performance Computing Conference in Denver16.8.2017 13:00Pressemelding

Professor Philip Diamond, Director General of the international Square Kilometer Array (SKA) project, will be the keynote speaker at SC17, the International Conference for High Performance Computing, Networking, Storage and Analysis in Denver, Nov. 12-17. This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20170816005129/en/ SC17 Keynote Speaker Philip Diamond (Photo: Business Wire) SKA is an international collaboration to build the world’s largest radio telescope that will change our understanding of space as we know it. Professor Diamond, accompanied by Dr. Rosie Bolton, SKA Regional Centre Project Scientist, will take SC17 attendees around the globe and out into the deepest reaches of the observable universe as they describe the SKA’s international partnership that will map and study the e

Scientist.com Ranks No. 155 on the 2017 Inc. 5000 List of Fastest-Growing Companies16.8.2017 12:06Pressemelding

Scientist.com, the leading marketplace for outsourced scientific services, today announced that it ranked no. 155 on Inc. magazine’s 2017 List of the 5000 Fastest-Growing privately-owned companies in America, and it ranked no. 11 in the country in the Health category. The San Diego-based company builds private marketplaces that connect many of the world’s largest life science research organizations with a global network of thousands of research suppliers. “Using Scientist.com, research organizations of pharmaceutical companies, biotech start-ups and academic and research institutes can get near instant access to thousands of the latest research technologies and services,” stated Paul A. Stone, JD, Partner at 5AM Ventures, a Scientist.com investor. “The marketplace saves researchers time, reduces costs, promotes access to innovation and ensures regulatory compliance. Scientist.com is im

I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.

Besøk vårt presserom